Taking control of Pharmavite and the Nature Made brand (1989)
On going after the brand before the market
In 1989, overseas acquisitions by Japanese pharmaceutical companies were aimed almost entirely at medicines, and it was rare to buy outright a health-food company in a category that did not yet even have a market at home. Otsuka Akihiko had made internationalisation his banner, on the view that only some twenty drug makers would survive worldwide in the end; yet the partner he chose was not drug discovery but Pharmavite of California, and Nature Made. The refusal to separate medicine from consumer goods shows in the very choice of what to buy.
That said, the choice did not bear fruit at once. Nature Made went on sale in Japan four years after the acquisition, in 1993, and the domestic supplement market took nearly another decade to get properly under way. To say the acquisition set up a second pillar is possible only because we already know how widely health-consciousness would spread afterwards. A decision to pre-empt a field that has no market by taking an overseas brand whole is judged on whether the company can endure the long time it takes to grow.
Revenue and net margin, FY1984–FY1994
Revenue in ¥ bn (bars) and net margin in % (line), for the years around the decision. Shaded columns are FY1989 onwards — after it was taken.
Source: securities reports
Read the full dossier in Japanese →
The Japanese edition carries the complete record of this decision — the situation that forced it, the options weighed, what actually followed, and the sources behind every claim.
Other key decisions at Otsuka Holdings
Yen amounts are converted at the average rate of each figure’s own year — not today’s rate; the revenue chart is shown in yen. Exchange rates & sources — the full ¥/US$ table →
Disclaimer
- This page is provided for general information only and is not investment advice, nor a recommendation to buy or sell any security.
- Figures are compiled independently and include our own estimates, approximations and machine-processed data; we make no warranty as to their accuracy or completeness.
- Sources are primarily each company’s securities reports and other public filings, but errors and omissions may remain.
- Any use of this information is at the reader’s own risk. Past performance does not indicate future results.
- Company names, logos and other marks belong to their respective owners.
Data API
Otsuka Holdings’s history, financials, executives and
shareholders are published as static JSON — no key, plain GET.
Full specification →
| Method | Endpoint | Returns |
|---|---|---|
| GET | /api/companies.json | All companies |
| GET | /api/4578/manifest.json | Resource index |
| GET | /api/4578/history.json | History overview |
| GET | /api/4578/timeline.json | Chronology |
| GET | /api/decisions.json | All management decisions (index) |
| GET | /api/4578/decisions.json | Management decisions (index) |
| GET | /api/4578/decisions/{slug}.json | One decision (full dossier) |
| GET | /api/4578/executives.json | Executives |
| GET | /api/4578/shareholders.json | Major shareholders |
| GET | /api/4578/financials.json | Financial statements |
| GET | /api/4578/financials-longterm.json | Long-term results |
| GET | /api/4578/segments.json | Business segments |
| GET | /api/4578/regions.json | Sales by region |
| GET | /api/4578/workforce.json | Workforce |